IMUX
Immunic, Inc. · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website imux.com
- Employees(FY) 80
- ISIN US4525EP1011
Performance
+0.4%
1W
-2.73%
1M
-1.19%
3M
+20.87%
6M
-17.0%
YTD
-31.22%
1Y
Profile
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 3 clinical for treatment of multiple sclerosis, including relapsing multiple sclerosis and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of retinoic acid receptor-related orphan nuclear receptor gamma truncated; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as celiac disease, inflammatory bowel disease, irritable bowel syndrome with diarrhea, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
Technical Analysis of IMUX 2024-05-10
Overview:
In analyzing the technical indicators for IMUX over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key indicators, we aim to offer valuable insights and predictions for the upcoming days.
Trend Analysi...
Recent News & Updates
- 2024-05-17 02:35
- 2024-05-16 05:54
- 2024-05-08 22:23
Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript(Insidermonkey)
- 2024-05-08 18:58
- 2024-05-07 18:36
Immunic: Q1 Earnings Snapshot(Yahoo Finance)
- 2024-05-07 18:30
- 2024-05-05 18:30
- 2024-04-30 22:02
- 2024-04-30 18:30
- 2024-04-29 18:30
- 2024-04-28 23:11
- 2024-04-03 18:30
- 2024-03-21 00:14
- 2024-03-20 23:37
- 2024-03-19 18:30
- 2024-03-07 17:53
- 2024-03-06 17:30
- 2024-02-28 17:30
- 2024-02-23 08:02
Immunic Inc (IMUX) Reports Year-End 2023 Financial Results(Yahoo Finance)
- 2024-02-22 22:04
Immunic, Inc. (NASDAQ:IMUX) Q4 2023 Earnings Call Transcript(Insidermonkey)
- 2024-02-21 21:59
- 2024-02-21 17:30
- 2024-02-14 17:30
- 2024-01-31 17:30
- 2024-01-04 17:35
- 2024-01-04 17:30
- 2023-11-20 17:30
- 2023-11-14 00:25
Immunic focusing on business development during Q4(Yahoo Finance)
- 2023-11-13 17:36
Immunic: Q3 Earnings Snapshot(Yahoo Finance)
- 2023-11-13 17:30
Page 1 of 4
previousnext